Stryker (SYK) Long-Term Investments (2009 - 2010)
Stryker's (SYK) quarterly Long-Term Investments came in at -$110.0 million in Q4 2010, down 170.06% year-over-year from $157.0 million in Q4 2009, and down 170.06% quarter-over-quarter from $157.0 million in Q4 2009.
Powered by 
Analysis
Stryker (SYK) Long-Term Investments (2009 - 2010) Analysis & Trends
Stryker (SYK) has reported Long-Term Investments for 2 consecutive years, with -$110.0 million the latest figure, recorded in Q4 2010.
- On a quarterly basis, Long-Term Investments fell 170.06% year-over-year to -$110.0 million in Q4 2010; TTM through Dec 2010 was -$110.0 million, a 170.06% decrease from a year earlier, with the FY2010 full-year figure at -$110.0 million, down 170.06% from the prior year.
- Long-Term Investments was -$110.0 million for Q4 2010 at Stryker, down from $157.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $157.0 million in Q4 2009 and troughed at -$110.0 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 178.31 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 124.32 Bn | 119.11 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 118.42 Bn | 109.60 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.22 Bn | 101.74 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.57 Bn | 66.03 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | - |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.17 Bn | 17.76 Bn | 1.54 Bn | - |